PROFUND ADVISORS LLC

Position in INSM — INSMED Inc

CIK 1129919 BETHESDA, MD

Position in INSM

as of Mar 31, 2026 · filed Apr 27, 2026 Compact

Position Value

$4,568,258

-$277,711 QoQ

Shares Held

27,937

+0.3% QoQ

Ownership

0.013%

of shares outstanding

% of Portfolio

0.17%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

13 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

PROFUND ADVISORS LLC holds $183,791,137 across 158 Biotechnology names. INSM ranks #4 (2.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	23,137	$10,331,595
2	REGN	Regeneron Pharmaceuticals, Inc.	10,332	$7,982,916
3	ALNY	Alnylam Pharmaceuticals, Inc.	14,647	$4,846,252
4	INSM	INSMED Inc This page	27,937	$4,568,258
5	APLS	Apellis Pharmaceuticals, Inc.	81,190	$3,266,273
6	MDGL	Madrigal Pharmaceuticals, Inc.	4,862	$2,545,111
7	TGTX	Tg Therapeutics, Inc.	76,039	$2,526,015
8	ARWR	Arrowhead Pharmaceuticals, Inc.	39,758	$2,492,826

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$4,568,258	27,937	+0.3%	Shares	Sole	2026-04-27
2025-12-31	$4,845,969	27,844	+144.8%	Shares	Sole	2026-02-06
2025-09-30	$1,637,825	11,373	-41.8%	Shares	Sole	2025-11-06
2025-06-30	$1,968,317	19,558	-39.1%	Shares	Sole	2025-08-07
2025-03-31	$2,448,680	32,097	-13.5%	Shares	Sole	2025-05-08
2024-12-31	$2,560,348	37,085	-19.7%	Shares	Sole	2025-02-14
2024-09-30	$3,371,578	46,186	+100.6%	Shares	Sole	2024-11-14
2024-06-30	$1,542,340	23,020	-56.5%	Shares	Sole	2024-08-13
2024-03-31	$1,436,343	52,943	-2.0%	Shares	Sole	2024-05-08
2023-12-31	$1,674,296	54,027	+13.3%	Shares	Sole	2024-02-14
2023-09-30	$1,204,096	47,687	-30.4%	Shares	Sole	2023-11-13
2023-06-30	$1,445,666	68,515	-4.0%	Shares	Sole	2023-08-10
2023-03-31	$1,217,284	71,395	—	Shares	Sole	2023-05-12
No filing history on record for this holder in this stock.